IL135087A - Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds - Google Patents

Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds

Info

Publication number
IL135087A
IL135087A IL13508798A IL13508798A IL135087A IL 135087 A IL135087 A IL 135087A IL 13508798 A IL13508798 A IL 13508798A IL 13508798 A IL13508798 A IL 13508798A IL 135087 A IL135087 A IL 135087A
Authority
IL
Israel
Prior art keywords
biologically active
active non
polypeptides
peptidyl compounds
purifying peptides
Prior art date
Application number
IL13508798A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL135087A publication Critical patent/IL135087A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL13508798A 1997-10-24 1998-10-08 Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds IL135087A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95776097A 1997-10-24 1997-10-24

Publications (1)

Publication Number Publication Date
IL135087A true IL135087A (en) 2005-05-17

Family

ID=25500093

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13508798A IL135087A (en) 1997-10-24 1998-10-08 Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds

Country Status (13)

Country Link
EP (1) EP1025126B1 (ja)
JP (1) JP4239131B2 (ja)
AT (1) ATE237636T1 (ja)
AU (1) AU740665B2 (ja)
CA (1) CA2306447C (ja)
DE (1) DE69813599T2 (ja)
DK (1) DK1025126T3 (ja)
ES (1) ES2195409T3 (ja)
HK (1) HK1031387A1 (ja)
IL (1) IL135087A (ja)
PT (1) PT1025126E (ja)
WO (1) WO1999021889A1 (ja)
ZA (1) ZA989424B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1412384T3 (da) 2001-06-28 2008-04-28 Novo Nordisk As Stabil formulering af modificeret GLP-1
JP4936884B2 (ja) 2003-06-03 2012-05-23 ノボ・ノルデイスク・エー/エス 安定化された薬学的ペプチド組成物
EP1633391B1 (en) 2003-06-03 2011-10-19 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
CN102784386A (zh) 2003-11-20 2012-11-21 诺沃挪第克公司 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
PL1789434T3 (pl) * 2004-08-31 2014-07-31 Novo Nordisk As Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
AU2005303777B2 (en) 2004-11-12 2010-12-16 Novo Nordisk A/S Stable formulations of insulinotropic peptides
US8921518B2 (en) 2005-12-23 2014-12-30 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (RPC)
US9488625B2 (en) 2010-12-15 2016-11-08 Baxalta GmbH Purification of factor VIII using a conductivity gradient
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US5446024A (en) * 1993-12-17 1995-08-29 Genentech, Inc. Purification of insulin-like growth factor

Also Published As

Publication number Publication date
AU740665B2 (en) 2001-11-08
WO1999021889A1 (en) 1999-05-06
CA2306447C (en) 2009-04-07
JP4239131B2 (ja) 2009-03-18
ES2195409T3 (es) 2003-12-01
DE69813599T2 (de) 2004-04-08
EP1025126B1 (en) 2003-04-16
CA2306447A1 (en) 1999-05-06
AU1072599A (en) 1999-05-17
HK1031387A1 (en) 2001-06-15
ATE237636T1 (de) 2003-05-15
EP1025126A1 (en) 2000-08-09
DK1025126T3 (da) 2003-08-04
JP2001521044A (ja) 2001-11-06
ZA989424B (en) 2000-04-17
DE69813599D1 (de) 2003-05-22
PT1025126E (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
IL135087A (en) Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds
IL110589A0 (en) Growth/differentiation factor of the TGF- beta family
ZA951372B (en) Antibody purification
IL77104A (en) Biologically active polypeptides and proteins and processes for purifying the same
ZA948551B (en) Chimeric proteins comprising borrelia polypeptides; uses therefor
EP0644769A4 (en) BIOLOGICALLY ACTIVE PEPTIDES WITH N-TERMINAL SUBSTITUTIONS.
AU648152B2 (en) Injection-type chemical composition for stabilization and reinforcement process using the same
AU6834294A (en) Metal chelates as spacer compounds in biologically active peptides
ZA942206B (en) Biologically active polypeptide fusion dimers
EP0614976A3 (en) Mammalian influx peptide transporter.
ZA934780B (en) A process for recovering a recombinant protein in biologically active from a solution containing inactive protein
IE902388L (en) Vasoactive intestinal peptide analogs.
EP0992584A3 (en) Purified mammalian FLT3 ligands and agonists and antagonists thereof
EP0783521B8 (en) Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
ZA978472B (en) Cysteine analogue containing peptides.
GB9511909D0 (en) Vaccine
ZA948410B (en) Metal-binding cysteine free peptides.
Basak et al. Affinity purification of proteinases by a combination of immobilized peptidyl aldehyde and semicarbazone
ATE175214T1 (de) Methode zur trennung von glykosylierten und unglykosylierten proteinen
HU9200507D0 (en) Novel method for the indentification of biologically active peptides from peptide mixtures in attacment-testing experiments
DE69420044D1 (de) Blutregulierende peptide
EP0893501A3 (en) Ferrichrome transport atp-binding protein
ZA978477B (en) Cysteine containing peptides.
UA35624C2 (uk) МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО
IT9047695A0 (it) Analizzatore automatico in cromatografia liquida ad elevata risoluzione (hplc) per il trattamento e la purificazione dei campioni e per la determinazione di sostanze in essi contenute.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired